Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro-Reference-Cited by-同舟云学术

Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro

Published:2015-12 Issue: Volume:220 Page:160-168
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Sriraman Shravan Kumar^ORCID,Geraldo Vananelia,Luther Ed,Degterev Alexei,Torchilin Vladimir

Funder

FAPESP

NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Targeting cancer metabolism: a therapeutic window opens;Vander Heiden;Nat. Rev. Drug Discov.,2011

3. Role of phosphatidylinositol 3, 4, 5-trisphosphate in cell signaling;Riehle,2013

4. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance;McCubrey;Biochim. Biophys. Acta,2007

5. MEK in cancer and cancer therapy;Neuzillet;Pharmacol. Ther.,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local, Sustained, and Targeted Co-Delivery of MEK Inhibitor and Doxorubicin Inhibits Tumor Progression in E-Cadherin-Positive Breast Cancer;Pharmaceutics;2024-07-25

2. Enhancing the efficacy of letrozole-loaded PEGylated nanoliposomes against breast cancer cells: In vitro study;Heliyon;2024-05

3. Targeting RAF dimers in RAS mutant tumors: From biology to clinic;Acta Pharmaceutica Sinica B;2024-05

4. Nanomaterials in Cancer Therapy;Advances in Medical Diagnosis, Treatment, and Care;2023-11-03

5. Nanoparticles in Medicine: Current Status in Cancer Treatment;International Journal of Molecular Sciences;2023-08-15